IL5 and dysplasia: In laboratory experiments, isolated cells expressing CCL20 and CCR4, stimulated by IL-5 and IL-7, demonstrated an increased ability of CD8+ T cells to penetrate dysplastic cells, thereby improving therapeutic efficiency in fighting dysplasia.